You are here: Home » 2021 » April » Archives for 27th

JobDiva Makes Hiring More Efficient by Integrating with Jobs on Facebook

NEW YORK, April 27, 2021 (GLOBE NEWSWIRE) — JobDiva is proud to announce an integration with Jobs on Facebook""one of the first integrations of its kind.

Jobs on Facebook makes it simple for employers and recruiters to post jobs, manage applications and communicate with candidates more easily. By synchronizing job openings, JobDiva's integration with Jobs on Facebook empowers businesses to reach candidates where they are spending significant amounts of time.

"At JobDiva, we are focused on reducing unemployment during these uncertain times, as well as matching the workforce with their desired opportunities by maximizing our clients' capabilities""and doing so quickly, in the interest of the public at large," said Gus Samra, JobDiva's Chief Revenue Officer. "JobDiva's integration with Jobs on Facebook is a signal example of our commitment to talent and client success, and we're ecstatic to offer this integration."

About JobDiva: JobDiva, the leading global ATS, is delivered to clients via the cloud. JobDiva stands as the top–tier ATS, defining the path of innovation in staffing technology.

Contact:
Bella Chen
Head of Marketing, JobDiva
Bella.chen@jobdiva.com
+1 212–384–6566

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/65890c74–c25d–4a3c–a1a1–b11802201711


GLOBENEWSWIRE (Distribution ID 8223999)

Taking action together – apply now

  • The United Nations Alliance of Civilizations (UNAOC) and the BMW Group established the Intercultural Innovation Award, which has promoted intercultural dialogue for ten years
  • To mark its tenth anniversary, organisations around the world are invited to submit innovative projects for consideration for the award (deadline: 27 May 2021)
  • The ten award–winners will receive a total of USD 200,000 in financial assistance
  • The focus is on projects dedicated to promoting diversity, integration, and social inclusion

MUNICH and NEW YORK, April 27, 2021 (GLOBE NEWSWIRE) — For the past ten years, the United Nations Alliance of Civilizations (UNAOC) and the BMW Group have invited organisations around the world to apply for the Intercultural Innovation Award. The two partners have used this award to support innovative projects promoting intercultural understanding.

"As we celebrate ten years of this ever–growing partnership between UNAOC and the BMW Group and now with the support of Accenture, we shall continue to collaborate to amplify the work of cutting–edge social innovators and promote diversity and inclusive societies," said Mr. Miguel ngel Moratinos, High Representative for UNAOC.

"In our anniversary year, we are not only celebrating a very successful partnership, but also using the Intercultural Innovation Award once again to appeal to people's feeling of community," said Ilka Horstmeier, member of the Board of Management of BMW AG responsible for Human Resources and new patron of the Intercultural Innovation Award. This takes on a whole new meaning in the face of Covid–19. As Horstmeier said, "We can only manage the added challenges of the pandemic by taking action together."

Wanted: projects for an inclusive and diverse society

This year, the focus will primarily be on projects promoting gender equality, countering violent extremism, hatred, and prejudices and advocating for art, culture, and sports as vehicles for social cohesion and diversity.

To leverage the social impact of the selected projects, all ten finalists will receive the same financial assistance. For this reason, with the support of Accenture, the partners have increased the financial award to USD 200,000. In addition, the finalists will receive individual and professional consulting and participate in various training sessions and workshops.

Interested organisations shall submit their application by 5:00 p.m. (EDT) on Thursday, 27 May 2021, at www.interculturalinnovation.org.

Contact:

Milena Pighi, BMW Group Corporate and Governmental Affairs, Spokesperson CSR
Contact +49–89–382–66563; Milena.PA.Pighi@bmw.de
https://www.bmwgroup.com

Alessandro Girola, Programming Coordinator, UNAOC
Contact: +1 (929) 274–6217; alessandrog@unops.org
https://www.unaoc.org


GLOBENEWSWIRE (Distribution ID 8224541)

Analytica Announces Expansion of Enhanced Infusion System into Middle East

  • Analytica signs agreement with Marwa for distribution, marketing and sales of the Enhanced Infusion System (EIS) in Egypt, Bahrain, Iran, Iraq, Jordan, Kuwait, Lebanon, Saudi Arabia and United Arab Emirates.
  • Patented IV add–in infusion system reduces infection and embolism risk and saves medical staff time for an overall lower total cost than existing equipment and practices.

BRISBANE, Australia, April 27, 2021 (GLOBE NEWSWIRE) — Analytica Limited (ASX:ALT), the Australian developer of the Enhanced Infusion System (EIS) and PeriCoach pelvic floor exercise system for the treatment of stress urinary incontinence, has entered into an agreement with Marwa's Office for Export & Import Medical Supplies (Marwa) to distribute, market and sell the EIS to hospital systems in Egypt, Bahrain, Iran, Iraq, Jordan, Kuwait, Lebanon, Saudi Arabia and United Arab Emirates.

The EIS technology was developed by Analytica under the project names AutoStart and AutoFlush and has been sold in Australia with the trade name FirstFlow, under limited license. EIS combines the AutoStart and AutoFlush patented technologies into a simple and inexpensive solution.

The patented float system automatically restarts IV fluid flow following medication delivery, thereby saving healthcare workers' time, reducing hospital costs and preventing the adverse events associated with air embolism and failure of Peripheral Intravenous Catheters (PIVC). The EIS reacts immediately, silently and without intervention or programming. It can be retrofitted to any existing infusion system design and can work in harmony with and improve the capability of any infusion pump or "bag' infusion system, regardless of sophistication.

Use of the EIS uniquely allows a completely closed infusion system, with integrity achieved by reducing the interactions believed to cause mechanical and vascular complications as well as good flushing and/or patency practice.

The EIS has an Australian TGA ARTG registration and USFDA 510(k) clearance. It is fully compliant with ISO 8536 infusion system and other relevant standards.

The EIS can markedly reduce legal risks by addressing multiple factors that can impact patients, clinicians and hospitals, including:

  • Air Embolism "" The EIS has a large and heavy float valve ensuring complete, long–term seal. The unique float maintains a seal even at extreme angles (up to 60 degrees from horizontal), making the device usable in ambulances, retrieval and military situations and reducing the risk of mortality and morbidity associated with air embolism.
  • Open/Closed Delivery System "" The needle–free access port is the only entry point, with only one syringe necessary per medication event. Using the existing 1L IV bag means replacement is less frequent than 100mL pre–mix bags, saving time and money and reducing the risk of contamination and infection.
  • Syringe Flush "" This feature eliminates the requirement to introduce an additional flushing syringe and bolus. Flushing prevents interactions between incompatible fluids/medications, thus reducing the risk of cross contamination and strengthening infection control.
  • Catheter Flush "" This feature reduces the risk of PIVC failure with the automatic, immediate restart of IV flow after medication delivery, which allows continuous maintenance flow to the flush line and catheter. This also maintains catheter patency by preventing internal luminal occlusion.
  • Medication Dilution "" The Interrupted Therapy feature allows the introduction of medication through EIS to accurately measure IV fluid mix rather than 3–way valve and bags.
  • Infection Risk "" Observational studies demonstrate high incidence of non–conformance to hand washing and flushing protocol. EIS limits access and infection opportunity.
  • Flushing pressure "" Bolus flush of catheter may vary based on syringe size and pressure. The proprietary float design ensures constant flushing pressure, reducing the risk of PIVC failure.

Given the health and legal risk–reduction features of the EIS, the home–based hospital care market represents a growth opportunity globally. The EIS is compact, rugged and does not require a pump or energy source, which makes it suitable for retrieval, military and third world needs without compromising risk.

To view a video about the operation and features of the EIS, please click here.

Marwa's Principal has extensive experience with the Egyptian health system, as a consultant and undersecretary of health for the Egyptian Health Insurance Organization Clinics (HIO) as well as leadership positions in the Egyptian Ministry of Health.

"Marwa has presented a compelling opportunity with experienced professionals to take Analytica's Enhanced Infusion System (EIS) into a large and growing market in the Middle East," said Dr. Michael Monsour, Chairman of Analytica Ltd. "We look forward to working with Marwa to expand the usage of our unique EIS technology."

For more information about Analytica and the Enhanced Infusion System, visit www.AnalyticaMedical.com

For investor or business inquiries, please contact: investorrelations@analyticamedical.com

For media inquiries, please contact: Annie Starr, astarr@6degreespr.com

About Analytica Limited

Analytica is a product development and commercialisation company based in Brisbane, Australia that is focussed on Class I and II medical device products.

Analytica is the developer of the Enhanced Infusion System (EIS), a combination of patented technologies developed under the project names AutoStart and AutoFlush. The EIS is a simple and inexpensive IV add–in technology to decrease nursing monitoring costs, reduce embolism risk, improve infection control, and automatically restart flow after medication delivery during intravenous fluid infusion.

Analytica is also the manufacturer of the PeriCoach System, an e–health treatment system for women who suffer stress urinary incontinence. This affects 1 in 3 women worldwide and is mostly caused by trauma to the pelvic floor muscles because of pregnancy, childbirth and menopause.

____________________

Trademark of ICU Medical Australia.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d7af8a18–4b05–4cae–a8bb–71d578ab84fc


GLOBENEWSWIRE (Distribution ID 8224474)